- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Proteochemometric modeling of HIV protease susceptibility ; volume:9 ; number:1 ; day:10 ; month:4 ; year:2008 ; pages:1-11 ; date:12.2008
BMC bioinformatics ; 9, Heft 1 (10.4.2008), 1-11, 12.2008
- Urheber
-
Lapins, Maris
- Beteiligte Personen und Organisationen
-
Eklund, Martin
Spjuth, Ola
Prusis, Peteris
Wikberg, Jarl ES
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-9-181
- URN
-
urn:nbn:de:1111-201602171955
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lapins, Maris
- Eklund, Martin
- Spjuth, Ola
- Prusis, Peteris
- Wikberg, Jarl ES
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
HIV-1 protease-induced apoptosis
Analysis of drug resistance in HIV protease
Evolution of drug resistance in HIV protease
Strukturelle Untersuchungen an HIV-1 Protease
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
Macaque models of enhanced susceptibility to HIV
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Molecular Mechanisms of Drug Resistance in HIV-1 Protease
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
HIV-1 protease-induced apoptosis
Analysis of drug resistance in HIV protease
Evolution of drug resistance in HIV protease
Strukturelle Untersuchungen an HIV-1 Protease
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
Macaque models of enhanced susceptibility to HIV
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Molecular Mechanisms of Drug Resistance in HIV-1 Protease
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Impact of the HIV-1 protease N88S substitution on protease inhibitor susceptibility and clinical response
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
HIV-1 protease-induced apoptosis
Analysis of drug resistance in HIV protease
Evolution of drug resistance in HIV protease
Strukturelle Untersuchungen an HIV-1 Protease
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
Macaque models of enhanced susceptibility to HIV
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Molecular Mechanisms of Drug Resistance in HIV-1 Protease